Mechanisms of skeletal muscle weakness.
Skeletal muscle weakness is an important feature of numerous -pathological conditions and it may also be a component in normal ageing. Decreased muscular strength can be due to decreased muscle mass and/or intrinsic defects in the muscle cells. In this chapter we will discuss decreased force production due to mechanisms intrinsic to skeletal muscle cells. We will mainly use data from mouse disease models to exemplify defects at various sites in the cellular activation-contraction pathway. We will show that depending on the underlying problem, muscle weakness can be due decreased Ca²(+) release from the sarcoplasmic reticulum, reduced myofibrillar Ca²(+) sensitivity and/or decreased ability of the cross-bridges to generate force.
Westerblad
Håkan
H
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. Hakan.Westerblad@ki.se
Place
Nicolas
N
Yamada
Takashi
T
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000172:deficiency / Q000235:genetics; D004195:Disease Models, Animal; D006609:High Mobility Group Proteins / Q000172:deficiency / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009046:Motor Neurons / Q000502:physiology; D009119:Muscle Contraction / Q000502:physiology; D018908:Muscle Weakness / Q000235:genetics / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D009210:Myofibrils / Q000502:physiology
D004268:DNA-Binding Proteins; D006609:High Mobility Group Proteins; C081930:Tfam protein, mouse; D000109:Acetylcholine; D002118:Calcium